Skip to content

HOME
PIPELINE
- LP-410 for Oral Graft versus Host Disease
- LP-50 for non-muscle invasive bladder cancer
FOR PATIENTS
- Oral Lichen Planus Clinical Trial
  - Oral Lichen Planus Registry
- LP-10 for Hemorrhagic Cystitis (HC)
  - Radiation Cystitis Registry
MANAGEMENT
PUBLICATIONS
INVESTORS
Recent News

Error 404 Page

Home » Error 404: Page not found

Oops, This Page Could Not Be Found!

404

Helpful Links

HOME
PIPELINE
FOR PATIENTS
MANAGEMENT
PUBLICATIONS
INVESTORS
Recent News

Search Our Website

Can't find what you need? Take a moment and do a search below!

Search for:

Lipella Pharmaceuticals Inc. Code of Ethics

CHARTERS:

Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Charter

Lipella Pharmaceuticals Inc.
7800 Susquehanna St, Suite 505
Pittsburgh, PA 15208
USA

2024 © Copyright - Lipella Pharmaceuticals, Inc.

Close Sliding Bar Area

Recent Posts

A Message from Our CEO, Dr. Jonathan Kaufman
Lipella Pharma Sees Positive Results for LP-10 Phase 2a Trial
Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry
Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate

Lipella Pharmaceuticals, Inc.

Phone: 412-894-1853

Email: Get In Touch Via Email

Reach Out

Investors

Corporate Overview
SEC Filings
Press Releases
Stock Quote
Events & Presentations
Corporate Governance
FAQ’s
Investor Relations Contact